-
201
-
202
-
203
DNA-loaded targeted nanoparticles as a safe platform to produce exogenous proteins in tumor B cells
Published 2025-01-01Get full text
Article -
204
Advances in regenerative medicine-based approaches for skin regeneration and rejuvenation
Published 2025-02-01Get full text
Article -
205
-
206
-
207
-
208
-
209
A high-throughput platform for single-molecule tracking identifies drug interaction and cellular mechanisms
Published 2025-01-01Get full text
Article -
210
Overall Survival of Patients with Metastatic Renal Cell Carcinoma Following the Introduction of Targeted and Immunotherapies: A Norwegian Retrospective, Real-World Registry Data St...
Published 2025-01-01“…Katarina Puco,1 Cathrine S Notland,2 Robert Szulkin,3,4 Christian Jonasson,5 Christian Beisland,6,7 Tom B Johannesen,8 Oddvar Solli,9 Jan Oldenburg,10,11 Daniel Heinrich12 1Department of Oncology, Hematology and Palliative Care, Lovisenberg Diaconal Hospital, Oslo, Norway; 2Department of Medical Affairs, Pfizer AS, Oslo, Norway; 3SDS Life Science, Stockholm, Sweden; 4Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Solna, Sweden; 5Department of Public Health and Nursing, Faculty of Medicine and Health Science, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; 6Department of Urology, Haukeland University Hospital, Bergen, Norway; 7Department of Clinical Medicine, University of Bergen, Bergen, Norway; 8Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway; 9Health and Value, Pfizer AS, Oslo, Norway; 10Department of Oncology, Akershus University Hospital HF, Lørenskog, Norway; 11Faculty of Medicine, University of Oslo, Oslo, Norway; 12Department of Radiotherapy and Oncology, Innlandet Hospital Trust HF, Division Gjøvik/Lillehammer, NorwayCorrespondence: Katarina Puco, Department of Oncology, Hematology and Palliative Care, Lovisenberg Diaconal Hospital, Oslo, Norway, Tel +47 416 86 298, Email katarina.puco@lds.noPurpose: In Norway, 5-year survival rates of patients with renal cell carcinoma (RCC) are increasing. …”
Get full text
Article -
211
-
212
-
213
Alloreactive-free CAR-VST therapy: a step forward in long-term tumor control in viral context
Published 2025-01-01Get full text
Article -
214
-
215
-
216
Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer
Published 2025-01-01Get full text
Article -
217
Oncogenic PIK3CA corrupts growth factor signaling specificity
Published 2024-12-01Get full text
Article -
218
Blue elixir of youth and wellness: The multicomponent-multitarget paradigm of Curcuma caesia Roxb
Published 2025-02-01Get full text
Article -
219
Age-Dependent Loss of Mitochondrial Function in Epithelial Tissue Can Be Reversed by Coenzyme Q10
Published 2018-01-01Get full text
Article -
220